Respiratory Inhalers Patent Landscape Market Respiratory Inhalers Patent Landscape Market Dublin, March 03, 2025 (GLOBE NEWSWIRE) -- The "Respiratory Inhalers Patent Landscape Report and Forecast 2024 ...

Respiratory Inhalers Patent Landscape Market Respiratory Inhalers Patent Landscape Market Dublin, March 03, 2025 (GLOBE NEWSWIRE) -- The "Respiratory Inhalers Patent Landscape Report and Forecast ...

Medications to treat upper respiratory infections usually include over-the-counter options to manage symptoms. Prescription drugs are helpful only in specific cases.

npj Primary Care Respiratory Medicine - Ease of use of the ELLIPTA dry powder inhaler: data from three randomised controlled trials in patients with asthma ...

Pneuma Respiratory has developed the first fully digital, soft mist inhaler. Early clinical studies have shown that the platform can effectively deliver a number of different types of medicines to ...

Cipla announces a new respiratory inhaler: Synchrobreathe (SB), a state-of-the-art breath-actuated inhaler which will bring relief to millions of patients with Obstructive Airway Disease.

Feedback is a critical component of any educational intervention. When it comes to feedback associated with inhaler technique education, there is a lack of knowledge on its role or its potential ...

Lower respiratory infections can also be treated at home with rest, fluids, and over-the-counter medications. In addition, you may need a bronchodilator inhaler if you are wheezing and short of ...

Overall, despite changes in inhaler technology, inhaler technique for both pMDI and DPI has not improved over 40 years (Sanchis et al, 2016). The UK Inhaler Group (UKIG) (2019) recommends that health ...

BOONE, N.C., Nov. 2, 2017 /PRNewswire/ -- Pneuma Respiratory has developed the first fully digital, soft mist inhaler. Early clinical studies have shown that the platform can effectively deliver a ...